RHY 2.99% 6.5¢ rhythm biosciences limited

Potential Australian market size for Colostat

  1. 280 Posts.
    lightbulb Created with Sketch. 95
    In 2022, the National Bowel Cancer Screening program posted out 862,000 poo tests to eligible Australians aged 50-74 years. (Less than half were returned, 432,000)

    Each test costs the government around $100, that's a waste of $43mil annually!!

    Rhythm have mentioned selling Colostat for $50 per test tbc.

    Imagine if Colostat is included under Medicare. And if it replaces the poo test...
    $25mil+ revenue in Australia alone.

    Even without government funding, the potential is there to sell upwards of say 100,000 tests annually in Australia alone during the very early phase. Not bad!
 
watchlist Created with Sketch. Add RHY (ASX) to my watchlist
(20min delay)
Last
6.5¢
Change
-0.002(2.99%)
Mkt cap ! $16.15M
Open High Low Value Volume
6.5¢ 6.6¢ 6.5¢ $9.479K 145.2K

Buyers (Bids)

No. Vol. Price($)
3 137779 6.5¢
 

Sellers (Offers)

Price($) Vol. No.
6.6¢ 450 1
View Market Depth
Last trade - 11.52am 25/06/2024 (20 minute delay) ?
RHY (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.